<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> and <z:hpo ids='HP_0001397'>fatty liver</z:hpo> are commonly associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but the genetic and functional bases linking <z:hpo ids='HP_0001397'>fatty liver</z:hpo> with <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:mp ids='MP_0002055'>diabetes</z:mp> are largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to investigate the association of <z:hpo ids='HP_0001397'>fatty liver</z:hpo> with <z:hpo ids='HP_0001513'>obesity</z:hpo> and other <z:mp ids='MP_0002055'>diabetes</z:mp>-related phenotypes and to define the genetic control of <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0001397'>fatty liver</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: We established 306 F2 mice by crossing Nagoya-Shibata-Yasuda (NSY) mice, an animal model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, with control C3H mice, and analysed their phenotypes </plain></SENT>
<SENT sid="3" pm="."><plain>Whole-genome screening of F2 mice was performed to identify the loci responsible for <z:hpo ids='HP_0001397'>fatty liver</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A strong association of <z:hpo ids='HP_0001397'>fatty liver</z:hpo> with <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> and <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> was observed in F2 mice </plain></SENT>
<SENT sid="5" pm="."><plain>Using whole-genome screening in 306 F2 mice, we mapped a new locus for <z:hpo ids='HP_0001397'>fatty liver</z:hpo> (Fl1n) on chromosome 6 (maximum logarithm of odds score [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MLS</z:e>] 10.0) and one for body weight (Bw1n) on chromosome 7 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MLS</z:e> 5.1) </plain></SENT>
<SENT sid="6" pm="."><plain>Fl1n was linked to epididymal fat weight as well as <z:hpo ids='HP_0001397'>fatty liver</z:hpo>, but its effects were opposite in the two tissues in that the NSY allele increased liver fat but decreased epididymal fat, suggesting a role of Fl1n in partitioning of fat mass </plain></SENT>
<SENT sid="7" pm="."><plain>The sequence of peroxisome proliferator-activated receptor gamma (Pparg), a candidate for Fl1n, showed allelic variation between NSY and C3H mice </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: These data suggest that <z:hpo ids='HP_0001397'>fatty liver</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> are phenotypically related but genetically independent </plain></SENT>
<SENT sid="9" pm="."><plain>Loci homologous to Fl1n and Bw1n are good candidate genes for susceptibility to <z:hpo ids='HP_0001397'>fatty liver</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> in humans </plain></SENT>
</text></document>